Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
about
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyIron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammationThe comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.Intravenous iron exposure and mortality in patients on hemodialysisIron supplementation and mortality in incident dialysis patients: an observational study.Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.Iron dosing in kidney disease: inconsistency of evidence and clinical practice.Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.Iron Therapy Challenges for the Treatment of Nondialysis CKD PatientsFerritin protein nanocages-the storyAt pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients.Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis.Renal aspects of thalassaemia a changing paradigm.Anaemia management and mortality risk in chronic kidney disease.How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysis.Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.Diagnosing and preventing iron overload.Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.Uses and interpretation of iron studies in patients on chronic dialysis.Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis.Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions.Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence.HFE gene mutation is a risk factor for tissue iron accumulation in hemodialysis patients.Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.Quantitative measurement of brain iron deposition in patients with haemodialysis using susceptibility mapping.Effect of intravenous iron on outcomes of acute kidney injury.Cumulative iron dose and resistance to erythropoietin.Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.HFE gene mutations are not risk factors for iron overload in European hemodialysis patients.Limiting Iron Supplementation for Anemia in Dialysis Patients-The Basis for Japan’s Conservative Guidelines
P2860
Q26752664-CDB7404F-5E0C-4C56-A231-2A6AD49C16C4Q26830874-FD7BFFC4-39BC-4C0A-983D-99413812F7E4Q33832885-806FA7A7-9529-4C37-83A8-38E4E1B20264Q34455198-B87D363F-5CCC-4B65-AC51-65C1F3F4A365Q34612274-BD998A15-6D41-4978-8BAF-2642472AA26EQ34704499-B99FF79E-8455-4C15-A9DF-48641F4CA75EQ35022235-8478DBA3-5040-4974-A4C3-837145F092E7Q35693595-3EFBD915-AA9A-4B3E-9630-4B293035852AQ37069943-0EB8F866-0BBA-4073-A272-DF48BD731283Q37278466-A6356BF2-4FCA-439B-A8F1-95EDFCAC5000Q37369071-AFB6EB54-D1EF-475D-9F01-32E91F77AEFCQ37570855-2A4BBFB7-C687-40DA-8AEA-CD5B677A3B3DQ37627538-3D2D7759-A154-4B36-8D3E-0824B6D5501DQ38017754-A636C8F4-CD55-41E9-93E7-89B7F8FE1846Q38084470-5DA71F0B-D425-4B6D-A23A-40F624B5E5FAQ38114158-BF2CA74E-7E2A-4761-9671-6583BEEACA86Q38884441-C3B0F0DE-DB1C-419D-8B78-D215D6C2D54AQ38946879-EAC6A127-80C0-4DCC-99DE-BA1EF41231AFQ39192941-55F69385-99FB-439D-AC1D-0316BD6FEA58Q39440902-0D9F6D0F-8E42-4C4A-B3A4-11A6686CCDD8Q40340927-253D3D87-7CF4-4850-87A2-A6B274655BAFQ45012876-8F34D70E-DCD8-427D-93F6-2053FB67BBA1Q46213470-57EF7270-7691-4C9B-BC1B-4F1EAE49E944Q47102467-B2746E26-6E07-45B5-91E9-B70013E3ECF9Q47102798-6AA9AAA8-5345-4EAD-A18F-360A96713672Q47111895-C463EF88-3E2A-4456-9BAA-BEF2F5D80216Q47140474-0C2B9851-EC99-4CCB-A7F1-86E4E22053E9Q47812077-444B2CE6-B2CC-4DFD-91D9-F774CA55004BQ47835950-EE5E9558-A51B-4289-B83F-8B39259DA12BQ48568405-C417310A-F5B2-49E0-8362-865B9B4B8955Q50266795-A5010214-0D1E-4F57-965D-EFD69DC2BB1FQ53150909-C5F1417F-7301-40F2-A271-3B6410940B72Q53823548-E96D18CE-BF00-48B1-AAA1-287DAC65B022Q54480672-5A3D432D-9D91-4BC7-9770-0BCC934D4A61Q57623255-F1A03B68-DD5E-457E-B1B2-AEECB227B27B
P2860
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@ast
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@en
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@nl
type
label
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@ast
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@en
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@nl
prefLabel
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@ast
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@en
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@nl
P2093
P2860
P50
P356
P1476
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
@en
P2093
Colin Harrison
Shyam Dheda
Susanne Betti
Timothy G St Pierre
P2860
P356
10.2215/CJN.04190510
P577
2010-09-28T00:00:00Z